MAIA
MAIA BIOTECHNOLG (MAIA)
NYSE
$1.47+$0.12 (+8.96%)
Price as of Jun 03, 2026 7:30 PM EDT
  • $84.5M
    Market Cap
  • -22.86%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
0
N/A
0
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-14.5M
+45.34%
-10.0M
-9.93%
-11.1M
+24.39%
-8.9M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
24.3M
+43.12%
17.0M
-15.98%
20.2M
+24.77%
16.2M
N/A
Operating Profit
-24.3M
+43.12%
-17.0M
-15.98%
-20.2M
+24.77%
-16.2M
N/A
Interest Income
313,954
-1.39%
318,367
+823.07%
34,490
+1,744.39%
1,870
N/A
Interest Expense
N/A
N/A
-57
-99.17%
-6,863
-1.49%
-6,967
N/A
Interest Income and Expense and Net
313,954
-1.37%
318,310
+1,052.17%
27,627
+642.02%
-5,097
N/A
Total Nonoperating Income and Expense
313,954
+550,696.49%
57
-99.17%
6,863
-1.49%
6,967
N/A
Income before Taxes
-24.3M
+43.12%
-17.0M
-14.24%
-19.8M
+21.91%
-16.2M
N/A
Income Taxes
N/A
N/A
2,000
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-22.4M
-3.69%
-23.3M
+17.61%
-19.8M
+25.39%
-15.8M
N/A
Net Income from Continuing Operations Applicable to Common
-22.4M
-3.69%
-23.3M
+17.61%
-19.8M
+21.91%
-16.2M
N/A
Basic EPS and Net Income
-0.70
-33.33%
-1.05
-29.53%
-1.49
-14.86%
-1.75
N/A
Diluted EPS and Net Income
-0.70
-33.33%
-1.05
-29.53%
-1.49
-14.86%
-1.75
N/A
Basic Weighted Average Shares
32.1M
+44.68%
22.2M
+67.38%
13.3M
+42.95%
9.3M
N/A
Diluted Weighted Average Shares
32.1M
+44.68%
22.2M
+67.38%
13.3M
+42.95%
9.3M
N/A
Balance Sheet
Cash and Cash Equivalents
8.7M
-9.82%
9.6M
+34.27%
7.2M
-34.70%
11.0M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
8.7M
-9.82%
9.6M
+34.27%
7.2M
-34.70%
11.0M
N/A
Total Current Assets
9.7M
-4.44%
10.2M
+34.22%
7.6M
-35.94%
11.8M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
2,800
0.00%
2,800
0.00%
2,800
0.00%
2,800
N/A
Total Assets
9.7M
-4.44%
10.2M
+34.21%
7.6M
-37.06%
12.0M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
5.8M
+52.38%
3.8M
-22.42%
4.9M
+51.03%
3.3M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
25,000
N/A
Total Long-Term Liabilities
1.5M
-44.53%
2.7M
+25.02%
2.2M
+478.02%
372,341
N/A
Total Liabilities
7.3M
+12.39%
6.5M
-8.02%
7.1M
+101.73%
3.5M
N/A
Retained Earnings
-109.6M
+25.67%
-87.2M
+36.35%
-64.0M
+44.73%
-44.2M
N/A
Total Stockholders Equity
N/A
N/A
3.6M
+661.16%
477,511
-94.39%
8.5M
N/A
Total Shares Outstanding
38.6M
+47.66%
26.2M
+53.99%
17.0M
+55.04%
11.0M
N/A
Cash Flow
Cash from Operating Activities
-18.8M
+20.00%
-15.7M
+20.15%
-13.1M
+12.14%
-11.7M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
17.9M
-1.49%
18.2M
+96.06%
9.3M
-22.98%
12.0M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-225.54%
-14.06%
-262.44%
+30.00%
-201.88%
N/A
N/A
N/A
Return on Equity
N/A
N/A
-1,131.02%
+156.98%
-440.12%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.66
-37.29%
2.65
+73.02%
1.53
N/A
N/A
N/A
Cash Ratio
1.48
-40.82%
2.51
+73.09%
1.45
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow